Veerhealth Care Limited
BSE: VEERHEALTH
Prev Close
21.87
Open Price
22.46
Volume
110,673
Today Low / High
21.5 / 22.46
52 WK Low / High
9.29 / 23.77
Range
21 - 23
The stock is currently available for trading on the Bombay Stock Exchange (BSE). Its price is 21.8, reflecting a change of -0.07 (-0.32007%). The expected target range on the BSE is 21 - 23. The stock is showing a downward trend on the BSE. This could indicate a potential risk for investors who are considering buying at this moment.
Veerhealth Care Limited Graph
Veerhealth Care Limited Price Target Predictions: Bullish vs. Bearish Scenarios with Ranges
If you are looking for the target price for Veerhealth Care Limited T1, T2, T3 for both Bullish and Bearish scenarios, here it is. For Bullish: T1, T2, T3. For Bearish: T1, T2, T3. The stock current price is 21.80, with potential price targets ranging from T1, T2, and T3 in both directions based on market conditions.
| Scenario | Price | Target | Range |
|---|---|---|---|
| Bullish Scenario | 21.80 | 22.02 | 19.82 - 24.22 |
| 22.24 | 17.79 - 26.68 | ||
| 22.45 | 15.72 - 29.19 | ||
| Bearish Scenario | 21.80 | 21.58 | 19.42 - 23.74 |
| 21.36 | 17.09 - 25.64 | ||
| 21.15 | 14.80 - 27.49 |
Overview of Veerhealth Care Limited
ISIN
INE882C01035
Industry
Medical - Pharmaceuticals
Vol.Avg
114,999
Market Cap
435,967,300
Last Dividend
0
Official Website
IPO Date
DCF Diff
27.98
DCF
-10
Financial Ratios Every Investor Needs
Annual Financial Income Report
| Date | Revenue | Co.Rev | GP | GPR | R&D Expenses | G&A Expenses | Operating Income | Net Income | EPS | EBITDA | NIR |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-03-31 | 16.67 Cr | 11.40 Cr | 5.27 Cr | 0.3162 | 0.00 Cr | 0.00 Cr | -0.45 Cr | 0.39 Cr | 0.22 | 1.68 Cr | 0.0235 |
| 2024-03-31 | 13.15 Cr | 9.13 Cr | 4.02 Cr | 0.3058 | 0.00 Cr | 0.41 Cr | 0.22 Cr | 0.41 Cr | 0.20 | 2.00 Cr | 0.0309 |
| 2023-03-31 | 13.23 Cr | 9.23 Cr | 4.00 Cr | 0.3022 | 0.00 Cr | 0.35 Cr | 0.18 Cr | 1.58 Cr | 0.79 | 1.74 Cr | 0.1196 |
| 2022-03-31 | 9.55 Cr | 6.92 Cr | 2.63 Cr | 0.2752 | 0.00 Cr | 0.30 Cr | -1.09 Cr | -0.07 Cr | -0.05 | 0.85 Cr | -0.0077 |
| 2021-03-31 | 10.48 Cr | 7.52 Cr | 2.97 Cr | 0.2831 | 0.00 Cr | 0.19 Cr | -0.49 Cr | 0.38 Cr | 0.27 | 1.26 Cr | 0.0362 |
Annual Financials Balance Sheet
| Date | C&C Equ. | Tot. Assets | Tot. Liab. | Stock. Equity | Tot. Debt | Net Debt | Inv. | PP&E (Net) | Curr. Def. Rev. | Non-Curr. Def. Rev. | LT Invest. | Curr. Liab. |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-03-31 | 1.16 Cr | 33.77 Cr | 11.55 Cr | 22.2188 Cr | 4.91 Cr | 3.75 Cr | 2.44 Cr | 19.87 Cr | 0.00 Cr | 0.00 Cr | 2.55 Cr | 3.5602 Cr |
| 2024-03-31 | 0.24 Cr | 28.12 Cr | 6.28 Cr | 21.8388 Cr | 0.00 Cr | -0.24 Cr | 1.40 Cr | 11.97 Cr | 0.00 Cr | 0.00 Cr | 2.10 Cr | 2.7730 Cr |
| 2023-03-31 | 3.61 Cr | 25.25 Cr | 3.82 Cr | 21.4326 Cr | 0.00 Cr | -3.61 Cr | 2.61 Cr | 12.01 Cr | 0.07 Cr | 0.00 Cr | 2.16 Cr | 0.9745 Cr |
| 2022-03-31 | 0.40 Cr | 20.15 Cr | 6.20 Cr | 13.9506 Cr | 0.00 Cr | -0.40 Cr | 2.12 Cr | 10.54 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 2.4628 Cr |
| 2021-03-31 | 0.10 Cr | 18.73 Cr | 4.69 Cr | 14.0432 Cr | 1.73 Cr | 1.63 Cr | 1.66 Cr | 9.48 Cr | 0.04 Cr | 0.00 Cr | 0.00 Cr | 1.5767 Cr |
Annual Financials Cash Flow Statement
| Date | Operating Cash | Investing Cash | Financing Cash | Free Cash | Cash Change | Cash at End | CapEx | Income | Debt Repay | Dividends | Inventory |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-03-31 | -0.3932 Cr | -8.2038 Cr | 9.5213 Cr | -9.2023 Cr | 0.9243 Cr | 1.1628 Cr | -8.8091 Cr | 0.3914 Cr | 9.9591 Cr | 0.0000 Cr | -1.0488 Cr |
| 2024-03-31 | 2.8957 Cr | -0.2751 Cr | -5.9945 Cr | 2.0703 Cr | -3.3739 Cr | 0.2385 Cr | -0.8255 Cr | 0.4061 Cr | -5.8302 Cr | 0.0000 Cr | 1.2097 Cr |
| 2023-03-31 | -0.6976 Cr | -1.7885 Cr | 5.6947 Cr | -2.7848 Cr | 3.2085 Cr | 3.6124 Cr | -2.0872 Cr | 1.5168 Cr | -0.0630 Cr | 0.0000 Cr | -0.4817 Cr |
| 2022-03-31 | 1.8091 Cr | -1.0898 Cr | -0.4172 Cr | 0.2251 Cr | 0.3021 Cr | 0.4039 Cr | -1.5840 Cr | -0.0736 Cr | -1.4116 Cr | 0.0000 Cr | -0.4610 Cr |
| 2021-03-31 | 1.0040 Cr | -0.0916 Cr | -0.8269 Cr | 0.5057 Cr | 0.0855 Cr | 0.1018 Cr | -0.4983 Cr | 0.3792 Cr | -0.6084 Cr | 0.0000 Cr | -0.4327 Cr |
Quarterly Financial Income Report
| Date | Revenue | Co.Rev | GP | GPR | Operating Income | Net Income | EPS | EBITDA | NIR |
|---|---|---|---|---|---|---|---|---|---|
| 2025-03-31 | 5.62 Cr | 4.50 Cr | 1.12 Cr | 0.1991 | -0.43 Cr | -0.11 Cr | -0.06 | 0.26 Cr | -0.0198 |
| 2024-12-31 | 3.84 Cr | 2.65 Cr | 1.19 Cr | 0.3104 | -0.10 Cr | 0.07 Cr | 0.04 | 0.32 Cr | 0.0184 |
| 2024-09-30 | 5.15 Cr | 2.98 Cr | 2.17 Cr | 0.4218 | 0.28 Cr | 0.30 Cr | 0.15 | 0.73 Cr | 0.0581 |
| 2024-06-30 | 2.06 Cr | 1.28 Cr | 0.79 Cr | 0.3824 | -0.20 Cr | 0.12 Cr | 0.06 | 0.34 Cr | 0.0588 |
| 2024-03-31 | 2.87 Cr | 2.94 Cr | -0.07 Cr | -0.0248 | -0.01 Cr | -0.52 Cr | -0.28 | 0.34 Cr | -0.1812 |
Quarterly Financials Balance Sheet
| Date | Cash & Equiv. | Short-Term Inv. | Cash & Short-Term | Net Receivables | Inventory | Total Curr. Assets | PP&E (Net) | Total Assets | Total Liabilities |
|---|---|---|---|---|---|---|---|---|---|
| 2025-03-31 | 1.16 Cr | 0.00 Cr | 1.16 Cr | 5.55 Cr | 2.44 Cr | 10.88 Cr | 19.87 Cr | 33.77 Cr | 11.55 Cr |
| 2024-12-31 | 0.00 Cr | 0.00 Cr | 0.80 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | -22.26 Cr |
| 2024-09-30 | 0.49 Cr | 0.31 Cr | 0.80 Cr | 8.64 Cr | 2.85 Cr | 12.64 Cr | 14.81 Cr | 30.97 Cr | 8.71 Cr |
| 2024-06-30 | 0.00 Cr | 0.00 Cr | 0.24 Cr | 0.00 Cr | 0.00 Cr | 0.24 Cr | 0.00 Cr | 0.00 Cr | -21.84 Cr |
| 2024-03-31 | 0.24 Cr | 0.00 Cr | 0.24 Cr | 3.92 Cr | 1.40 Cr | 13.46 Cr | 11.97 Cr | 28.12 Cr | 6.28 Cr |
Quarterly Financials Cash Flow Statement
| Date | Net Income | Operating Cash Flow | Investing Cash Flow | Financing Cash Flow | Net Cash Change | Cash at End | Cash at Beginning | CapEx | Free Cash Flow |
|---|---|---|---|---|---|---|---|---|---|
| 2024-12-31 | 0.07 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr |
| 2024-09-30 | 0.30 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr |
| 2024-06-30 | 0.12 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr |
| 2024-03-31 | -0.52 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr |
| 2023-12-31 | 0.19 Cr | 0.36 Cr | 0.00 Cr | 0.00 Cr | 0.36 Cr | 1.51 Cr | 1.15 Cr | 0.00 Cr | 0.36 Cr |
Splits History
| Date | Label | Split Ratio |
|---|---|---|
| 2023-09-22 | September 22, 23 | 2:1 |
| 2017-01-13 | January 13, 17 | 1:10 |
| 2016-11-29 | November 29, 16 | 1:10 |
| 2005-09-28 | September 28, 05 | 10:1 |
Similar Stocks: Medical - Pharmaceuticals
| Company Name | Symbol | Price | Market Cap | Volume |
|---|---|---|---|---|
| MedPlus Health Services Limited | MEDPLUS | ₹821.25 | ₹98,339,283,675.00 | ₹72,992.00 |
Key Executives
Gender: male
Year Born:
Gender: male
Year Born:
Gender: male
Year Born: 1981
Gender: female
Year Born: 1992
FAQs about Veerhealth Care Limited
The CEO is Bhavin Satish Shah.
The current price is ₹21.80.
The range is ₹9.29-23.77.
The market capitalization is ₹43.60 crores.
The P/E ratio is 101.25.
The company operates in the Healthcare sector.
Overview of Veerhealth Care Limited (ISIN: INE882C01035) is a leading Medical - Pharmaceuticals in India. With a market capitalization of ₹43.60 crores and an average daily volume of 114,999 shares, it operates in the Medical - Pharmaceuticals. The company last declared a dividend of ₹0.